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Pull-downTransitions in DNA structure have the capacity to regulate genes, but have been poorly characterised in eukary-
otes due to a lack of appropriate techniques. One important example is DNA supercoiling, which can directly reg-
ulate transcription initiation, elongation and coordinated expression of neighbouring genes. DNA supercoiling is
the over- or under-winding of the DNA double helix, which occurs as a consequence of polymerase activity and is
modulated by topoisomerase activity [5]. To map the distribution of DNA supercoiling in nuclei, we developed
biotinylated 4,5,8-trimethylpsoralen (bTMP) pull-down to preferentially enrich for under-wound DNA. Here
we describe in detail the experimental design, quality controls and analyses associated with the study by
Naughton et al. [13] that characterised for the ﬁrst time the large-scale distribution of DNA supercoiling in
human cells (GEO: GSE43488 and GSE43450).
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Experimental design, materials and methods
Experimental design
Our approach to mapping unrestrained DNA supercoiling utilises the
preferential intercalation of TMP into under-wound DNA helices [2,16].
Using a biotin tagged TMP molecule (bTMP) [14] we are able to enrich
for TMP bound DNA by streptavidin pull-down and identify the relativeen access article under the CC BY-NCsupercoiling across genomic loci byqPCR andmicroarray analysis. Anum-
ber of previous studies have compared TMP binding in the presence and
absence of transcription and topoisomerase inhibitors to identify transi-
tions in unrestrained DNA supercoiling at promoters and over more ex-
tensive regions [1,2,5,7,9–12]. However, these studies were unable to
adequately compare the distribution of unrestrained DNA
supercoiling within samples, as they lack a suitable control for ob-
served TMP bias associated with sequence and chromatin struc-
ture [3,8,17]. In our experiments we have more thoroughly
controlled for the binding and distribution of the bTMP molecule,
using a bTMP pull-down of sonicated genomic DNA and in cells
treated with the nicking agent bleomycin which relieves DNA su-
percoils. These bTMP binding controls are essential to understand
the relative distribution of DNA supercoiling in vivo as they give a
base-line bTMP distribution independent of sequence/chromatin
preference. In our experiments bTMP distribution in bleomycin
treated cells and genomic DNA are comparable and they can be
used interchangeably as the base-level distribution of bTMP
binding.
To characterise the distribution of DNA supercoiling in nuclei, the
base-line bTMP distribution (log2(bTMP genomic/input)) is subtracted
from the bTMP distribution of untreated cells (log2(bTMP control/
input)) or cells treated with transcription and/or topoisomerase inhibi-
tors (log2(bTMP inhibitor/input)). In untreated cells this bTMP distribu-
tion reﬂects the steady-state distribution of unrestrained DNA
supercoiling in the human genome, with regions of relative under- and
over-winding observed over large domains and around gene promoters
[13]. Changes in DNA supercoiling after treatment with transcription or
topoisomerase inhibitors highlight the dynamic nature of the transitions
in DNA structure.-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
265S. Corless et al. / Genomics Data 2 (2014) 264–267bTMP pull down data
Retinal pigmented epithelial (RPE1) cells with an almost normal
human karyotype are incubated in the dark with bTMP (500 μg/ml)
followed by 10 minute UV exposure (365 nm) to photo-cross-link
bTMP to the DNA in vivo. The DNA is then puriﬁed from cells and the in-
corporation of bTMP conﬁrmed by dotblot using an anti-streptavidin-
HRP antibody. A standard ChIP protocol is then used to isolate bTMP
bound DNA, followed by whole genome ampliﬁcation of sample/input
DNA and random prime labelling with Cy5 or Cy3 for microarray
hybridisation.
We use customAgilent arrays andNimblegen 2.1Mpromoter arrays
according to standard manufacturer's protocols. Microarray samples
from Naughton et al. [13] are deposited in GEO under accession num-
bers GSE43448 and GSE43450.Quality control and normalisation
Microarray text ﬁles are read, pre-processed and normalised using
the RINGO Bioconductor package in R [18]. Arrays are checked for a uni-
form hybridisation pattern and the signal intensities are compared
across arrays to ensure similarity within ﬂuorophore types (Fig. 1). In
rare cases arrays show scratches, drying marks and other artefacts
that result in them being discarded from subsequent analyses
(Fig. 1a). Furthermore, if the observed signal intensity of the pre-
normalised arrays has a non-normal distribution for one/both of the
ﬂuorophores then this represents a systematic technical bias and





























Fig. 1. Quality control and data normalisation. a) Establishing the array scan quality. Signal dist
including scratches (right hand panel), drying marks, dust particles, etc. b) Intra- and inter-ar
intensity bias is corrected for by VSN normalisation. MA plot displaying the observed signal r
(a) ((log(R) + log(G))/2) for a single microarray. R is red and G is green.In addition to technical problems that prevent the interpretation of
microarray data there are inherent biases that can be corrected for
through data normalisation [15]. The difference in signal intensity be-
tween Cy3 and Cy5 for a single array (intra-array variation) and be-
tween individual ﬂuorophores across arrays (inter-array variation)
must be accounted for in order to interpret changes in signal intensity
between experiments (Fig. 1b pre-normalisation). Additionally, there
is a signal intensity bias that is universal to microarray experiments in
which the observed signal intensity ratio (M) varies with the average
signal intensity ratio (A) (Fig. 1c pre-normalisation). To correct these
biases, normalisation is performed using a variance stabilising algo-
rithm (VSN) from the Limmapackage [4] (Fig. 1b and c post vsnnormal-
isation). Other normalisation procedures, such as a sequential loess and
scale normalisation, give almost identical results in the ﬁnal analyses
(data not shown).
To correct for DNA supercoiling independent differences in bTMP
binding across array samples, the base-line bTMP bound to genomic
DNA is subtracted from bTMP bound in cells. This quantitative measure
of bTMP binding allows the comparison of DNA supercoiling across loci
in vivo, with positive number showing an enrichment of under-wound
DNA and negative numbers showing a depletion of under-wound DNA.
All subsequent analysis is performed on the mean of this corrected
dataset from duplicate experiments for each experimental condition.Data analysis
The relative distribution of under-wound DNA in each experimental
condition is visualised using the ‘zoo’ package in R [19]. The ‘zoo’ data5 10 15
t array intensity 
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ribution across arrays can be used to identify technical problems with array hybridisation
ray signal intensity variation is corrected for by VSN normalisation. c) Fluorophore signal
atio (M) (log2(R)/log2(G)) against the average signal intensity of the two ﬂuorophores
Fig. 2. Identiﬁcation and classiﬁcation of DNA supercoil domains. a) Data smoothing demarcatesDNA supercoiling domains. Plot of control DNA supercoiling corrected for bTMPbinding to
genomic DNA smoothed using an 11 probe, 31 probe or 101 probe rollingmedian. b) An edgeﬁlter identiﬁes DNA supercoil domain boundaries. Output of the edge ﬁlter (black) identiﬁes
peak differences in log2(bTMP control cells/input)− log2(bTMP amanitin treated cells/input) between adjacent 300 probe (~30 kb) windows. The cut-off of 0.2 is used to identify major
peaks. The boundaries (broken red lines) correspondwellwith the smoothed control (‘Con’) and amanitin treated (‘Am’) DNA supercoil distributions. Eachdomain is assigned a type based
on whether control is more under-wound, more over-wound or is stable when compared to the alpha amanitin treated DNA supercoil distribution.
266 S. Corless et al. / Genomics Data 2 (2014) 264–267structure forms an ordered index of observations that is ideal for pro-
cessing tiled genomic data. Using ‘plot’ to view the ordered distribution
of DNA supercoiling across whole loci, domain-scale enrichments and
depletions of under-wound DNA are identiﬁed. This distribution is clar-
iﬁed by smoothing using the ‘rollingMedian’ function with a window
size of 11, 31 and 101 probes (Fig. 2a). DNA supercoil distribution ﬁg-
ures are plotted with a 101 probe smoothing (~10 kb) to demarcate
supercoiling domains [13], but it is vital that subsequent analysis is
not performed on heavily smoothed data to avoid a loss of resolution.
To further characterise supercoiling domains observed in the
smoothed data a custom edge ﬁlter was designed based on Guelen
et al. [6]. Smoothed data frombTMPpull-down experiments on untreat-
ed cells (‘Con’) and cells treated with the transcription inhibitor α-
amanitin (‘Am) identify consistent domain boundaries, with substantial
changes to the distribution of DNA supercoilingwithin these boundaries
(Fig. 2b). Therefore, edges were deﬁned based on the difference be-
tween ‘Con’ and ‘Am’ DNA supercoil distribution. To deﬁne the bound-
aries a comparison was made for 300 probes up- and down-stream ofeach probe across a locus, and a cut-off set that matches the most dis-
tinct supercoil boundaries (Fig. 2b). To avoid edge effects the 300 probes
at the start and end of a locus are removed. In the supercoiling data ob-
tained from Agilent arrays, as presented in Naughton et al. [13], the cut-
off was set at 0.2 which captures the most prominent domain bound-
aries (Fig. 2b). In addition this cut-off identiﬁes a number of very narrow
boundaries (b2000 bp) which appear to correspond to CpG islands (not
shown). These boundaries show no relationship to DNA supercoil do-
mains and are removed for subsequent analyses. Therefore, using the
edge ﬁlter under these conditions 90 domains are identiﬁed in
11.9 Mb of Agilent array data and 607 domains are identiﬁed across
chromosome 11 (135 Mb). Domains are then classiﬁed based on the
mean change in DNA supercoiling upon transcription inhibition into
under-wound (N0.5), over-wound (b−0.5) and stable (−0.5 to 0.5)
(Fig. 2b). This classiﬁcation allows for a direct comparison of regions
of the genome with similar DNA supercoil properties in our RPE1 cell-
line. Importantly, when repeating these experiments in a new cell line
or on a new array platform it is essential to re-calibrate the cut-offs
267S. Corless et al. / Genomics Data 2 (2014) 264–267used to deﬁne supercoiling domains and their boundaries through care-
ful observation of the underlying data.Discussion
We describe here a method for mapping DNA supercoiling in vivo
through an analysis of bTMP distribution by microarray. By properly
controlling for the complex and poorly characterised sequence prefer-
ence of bTMP using genomic DNA and bleomycin controls, our method
can compare the distribution of unrestrained DNA supercoilingwithin a
sample. Using this technique we have identiﬁed that ~100 kb DNA
supercoiling domains exist in human cells, which are modulated by
transcription and topoisomerase activity [13]. In future work the
bTMP pull-down technique will be used to further probe the distribu-
tion and function of DNA supercoiling in genome structure and
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